Du är här

2014-05-01

Novel Pain Treatment is Now Available: iovera System Harnesses the Power of Cold to Block Pain

REDWOOD CITY, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- California based
myoscience, inc., is pleased to announce the launch of the revolutionary
iovera° health treatment, a new option to immediately block pain using the
body's natural response to cold without the use of drugs or surgery.

Vinod Dasa, MD, Associate Professor of Orthopaedic Surgery in New Orleans, one
of the first to perform the treatment has treated over 50 patients and is
excited about the possibilities. "I think this technology has the potential
to change the current paradigm of acute and chronic pain management. The
patients that I have treated are all grateful to have an option that is very
safe and that has allowed them to get back to functionality quickly."

Clint Carnell, CEO of myoscience, has witnessed the powerful patient outcomes
"It's rewarding to provide this revolutionary treatment to patients suffering
from pain. We have developed a product that delivers a treatment that is
safe, effective and most importantly free of the negative systemic side
effects often common with today's therapeutic options."

The iovera° health treatment utilizes myoscience's platform technology, the
Focused Cold TherapyTMdelivery system, to precisely target peripheral nerves,
temporarily interrupting pain signaling pathways. This precise cold treatment
causes a reversible nerve block based on a process called 2nddegree
degeneration that is followed by a predictable restoration of nerve function.
The iovera° system offers patients a new treatment option, with no systemic
side effects and nothing being injected into the body. Most patients
experience instant pain relief after an iovera° treatment, with results that
can last up to three months.

For physicians and patients who would like additional information, please
visitwww.ioverahealth.comor email us directly atcontact@myoscience.com.

ABOUT MYOSCIENCE

Silicon Valley, California-based myoscience is a privately-held medical device
company committed to making its platform technology, Focused Cold Therapy,
the standard of care for the treatment of peripheral nerve conditions.
Focused Cold Therapy is the patented technology delivered by the ioveraº
system. The ioveraº system is currently approved in Europe and Canada for
temporary wrinkle reduction, temporary pain reduction and treatment of
dermatologic conditions, and is indicated in the United States for use in
pain management and general surgical use. For more information, please visit
www.myoscience.com
.

The myoscience logo is available
athttp://www.globenewswire.com/newsroom/prs/?pkgid=13581

© 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are
trademarks of myoscience.

CONTACT: 1600 Seaport Blvd., Ste. 450 / Redwood City, CA
Tel: 650.474.2600 / iovera.com

MEDIA RELATIONS
Jay Patel / myoscience@hypertonic.com

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: myoscience via Globenewswire

HUG#1782056

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.